Abstract

Zika (ZIKV) and dengue virus (DENV) are transmitted to humans by Aedes mosquitoes. However, the molecular interactions between the vector and ZIKV remain largely unexplored. In this work, we further investigated the tropism of ZIKV in two different Aedes aegypti strains and show that the virus infection kinetics, tissue migration, and susceptibility to infection differ between mosquito strains. We also compare the vector transcriptome changes upon ZIKV or DENV infection demonstrating that 40% of the mosquito’s midgut infection-responsive transcriptome is virus-specific at 7 days after virus ingestion. Regulated genes included key factors of the mosquito’s anti-viral immunity. Comparison of the ZIKV and DENV infection-responsive transcriptome data to those available for yellow fever virus and West Nile virus identified 26 genes likely to play key roles in virus infection of Aedes mosquitoes. Through reverse genetic analyses, we show that the Toll and the Jak/Stat innate immune pathways mediate increased resistance to ZIKV infection, and the conserved DENV host factors vATPase and inosine-5′-monophosphate dehydrogenase are also utilized for ZIKV infection.

Highlights

  • Aedes mosquitoes are the primary vectors of Zika virus (ZIKV), dengue virus (DENV), and chikungunya virus (CHIKV) which are currently the most devastating arboviral pathogens

  • Our study suggests that the kinetics of ZIKV infection intensity and prevalence differ between the A. aegypti Orl and Rock strains

  • While the Rock strain appeared to be more permissive to ZIKV infection at the stage of midgut and disseminated infection, virus infection intensity and prevalence of ZIKV in the salivary glands were similar between the two mosquito strains

Read more

Summary

Introduction

Aedes mosquitoes are the primary vectors of Zika virus (ZIKV), dengue virus (DENV), and chikungunya virus (CHIKV) which are currently the most devastating arboviral pathogens. ZIKV infections are mild or asymptomatic; in contrast to DENV and CHIKV infections, ZIKV has been associated with Guillain-Barré syndrome in adults, and a heightened risk of microcephaly and other birth defects in prenatally infected infants (Cao-Lormeau et al, 2016; Johansson et al, 2016). No preventive or therapeutic drugs exist against these pathogens. The control of Aedes mosquitoes remains the primary approach to limit viral transmission (Morrison et al, 2008). Aedes aegypti – Zika Virus Molecular Interactions

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call